One prominent study reported a tumour suppressor role for GPER and demonstrated that the GPER-specific agonist, G1, can reduce proliferation and enhance apoptosis in CRC cell lines as well as reducing tumour growth in a CRC tumour xenograft [16]. The gene discussed is GPER1; the disease is neoplasm.